Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2
Authors:
Open Access
- 13 October 2022
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 17 (22)
Abstract
New antimalarial treatments with novel mechanism of action are needed to tackle Plasmodium falciparum infections that are resistant to first‐line therapeutics. Here we report the exploration of MMV692140 (2) from the Pathogen Box, a collection of 400 compounds that was made available by Medicines for Malaria Venture (MMV) in 2015. Compound 2 was profiled in in vitro models of malaria and was found to be active against multiple life‐cycle stages of Plasmodium parasites. The mode of resistance, and putatively its mode of action, was identified as Plasmodium falciparum translation elongation factor 2 (PfeEF2), which is responsible for the GTP‐dependent translocation of the ribosome along mRNA. The compound maintains activity against a series of drug‐resistant parasite strains. The structural motif of the tetrahydroquinoline (2) was explored in a chemistry program with its structure‐activity relationships examined, resulting in the identification of an analog with 30‐fold improvement of antimalarial asexual blood stage potency.Keywords
Funding Information
- World Health Organization
This publication has 16 references indexed in Scilit:
- A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaScience Translational Medicine, 2015
- A novel multiple-stage antimalarial agent that inhibits protein synthesisNature, 2015
- Subtle Changes in Endochin-Like Quinolone Structure Alter the Site of Inhibition within the Cytochrome bc 1 Complex of Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2015
- Spread of Artemisinin Resistance in Plasmodium falciparum MalariaNew England Journal of Medicine, 2014
- A molecular marker of artemisinin-resistant Plasmodium falciparum malariaNature, 2013
- P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-ActionPLOS ONE, 2012
- Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug DiscoveryScience, 2011
- Thousands of chemical starting points for antimalarial lead identificationNature, 2010
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium modelsExperimental Parasitology, 2007